Analysis of single nucleotide polymorphisms within ADAM12 and risk of knee osteoarthritis in a Chinese han population

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Wang, Lin ^a   Guo, Lin ^a   Tian, Fengde ^a   Hao, Ruihu ^a   Yang, Tiejun ^a  

^a DALIAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM12 PROTEIN; UNCLASSIFIED DRUG; ADAM 12 PROTEIN; MEMBRANE PROTEIN;

AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAN CHINESE; HOMOZYGOTE; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; OSTEOARTHRITIS, KNEE;

ADAM PROTEINS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OSTEOARTHRITIS, KNEE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84947650100     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/518643     Document Type: Article

References (23)

1. J. Samuels, S. Krasnokutsky, and S. B. Abramson, "Osteoarthritis: a tale of three tissues," Bulletin of the NYU Hospital for Joint Diseases, vol. 66, no. 3, pp. 244-250, 2008.
2. W. Zhang, M. Doherty, N. Arden et al., "EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)," Annals of the Rheumatic Diseases, vol. 64, no. 5, pp.669-681, 2005.
3. W. Zhang, R. W. Moskowitz, G. Nuki et al., "OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines," Osteoarthritis and Cartilage, vol. 16, no. 2, pp. 137-162, 2008.
4. W. Zhang, R. W. Moskowitz, G. Nuki et al., "OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence," Osteoarthritis and Cartilage, vol. 15, no. 9, pp. 981-1000, 2007.
5. W. Zhang, G. Nuki, R.W. Moskowitz et al., "OARSI recommendations for themanagement of hip and knee osteoarthritis. Part III: changes in evidence following systematic cumulative update of research published through January 2009," Osteoarthritis and Cartilage, vol. 18, no. 4, pp. 476-499, 2010.
6. K. M. Jordan, N. K. Arden, M. Doherty et al., "EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)," Annals of the Rheumatic Diseases, vol. 62, no. 12, pp. 1145-1155, 2003.
7. A. M. Valdes, D. J. Hart, K. A. Jones et al., "Association study of candidate genes for the prevalence and progression of knee osteoarthritis," Arthritis & Rheumatism, vol. 50, no. 8, pp. 2497-2507, 2004.
8. K. L. Limer, K. Tosh, S.R. Bujac et al., "Attempt to replicate published genetic associations in a large, well-defined osteoarthritis case-control population (the GOAL study)," Osteoarthritis and Cartilage, vol. 17, no. 6, pp. 782-789, 2009.
9. S. Lou, Z. Zhao, J. Qian, K. Zhao, and R. Wang, "Association of single nucleotide polymorphisms in ADAM12 gene with susceptibility to knee osteoarthritis: a case-control study in a Chinese Han population," International Journal of Clinical and Experimental Pathology, vol. 7, pp. 5154-5159, 2014.
10. A. Okada, S. Mochizuki, T. Yatabe et al., "ADAM-12 (Meltrin α) is involved in chondrocyte proliferation via cleavage of insulinlike growth factor binding protein 5 in osteoarthritic cartilage," Arthritis & Rheumatism, vol. 58, no. 3, pp. 778-789, 2008.
11. I. Kerna, K. Kisand, P. Laitinen et al., "Association of ADAM12- S protein with radiographic features of knee osteoarthritis and bone and cartilage markers," Rheumatology International, vol.32, no. 2, pp. 519-523, 2012.
12. A. M. Valdes, M. Doherty, and T.D. Spector, "The additive effect of individual genes in predicting risk of knee osteoarthritis," Annals of the Rheumatic Diseases, vol. 67, no. 1, pp. 124-127, 2008.
13. M.-H. Shin, S.-J. Lee, S.-J. Kee et al., "Genetic association analysis of GDF5 and ADAM12 for knee osteoarthritis," Joint Bone Spine, vol. 79, no. 5, pp. 488-491, 2012.
14. I. Meulenbelt, "Osteoarthritis year 2011 in review: genetics," Osteoarthritis and Cartilage, vol. 20, no. 3, pp. 218-222, 2012.
15. H. Takahashi, M. Nakajima, K. Ozaki, T. Tanaka, N. Kamatani, and S. Ikegawa, "Prediction model for knee osteoarthritis based on genetic and clinical information," Arthritis Research and Therapy, vol. 12, no. 5, article R187, 2010.
16. A. M. Valdes, M. van Oene, D. J. Hart et al., "Reproducible genetic associations between candidate genes and clinical knee osteoarthritis in men andwomen," Arthritis&Rheumatism, vol.54, no. 2, pp. 533-539, 2006.
17. I. Kerna, K. Kisand, A. E. Tamm, M. Lintrop, K. Veske, and A. O. Tamm, "Missense single nucleotide polymorphism of the ADAM12 gene is associated with radiographic knee osteoarthritis in middle-aged Estonian cohort," Osteoarthritis and Cartilage, vol. 17, no. 8, pp. 1093-1098, 2009.
18. T. Aigner, S. Soeder, and J. Haag, "IL-1β and BMPS-interactive players of cartilage matrix degradation and regeneration," European Cells & Materials, vol. 12, pp. 49-56, 2006.
19. B. J. Gilpin, F. Loechel, M.-G. Mattei, E. Engvall, R. Albrechtsen, and U. M. Wewer, "A novel secreted form of human ADAM 12 (meltrin α) provokes myogenesis in vivo," Journal of Biological Chemistry, vol. 273, no. 1, pp. 157-166, 1998.
20. F. Loechel, J. W. Fox, G. Murphy, R. Albrechtsen, and U. M. Wewer, "ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3," Biochemical and Biophysical Research Communications, vol. 278, no. 3, pp. 511-515, 2000.
21. C. K. Thodeti, C. Fröhlich, C. K. Nielsen et al., "ADAM12- mediated focal adhesion formation is differently regulated by β1 and β3 integrins," FEBS Letters, vol. 579, no. 25, pp. 5589-5595, 2005.
22. K. Iba, R. Albrechtsen, B. J. Gilpin, F. Loechel, and U. M. Wewer, "Cysteine-rich domain of human ADAM12 (meltrin α) supports tumor cell adhesion," American Journal of Pathology, vol. 154, no. 5, pp. 1489-1501, 1999.
23. J. Laigaard, T. Sørensen, C. Fröhlich et al., "ADAM12: a novel first-trimester maternal serum marker for Down syndrome," Prenatal Diagnosis, vol. 23, no. 13, pp. 1086-1091, 2003.